-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Panbela Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Panbela Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$8.1M, a 37.9% decline year-over-year.
- Panbela Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$29.7M, a 52.2% decline year-over-year.
- Panbela Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$25.6M, a 24.8% increase from 2022.
- Panbela Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$34.1M, a 241% decline from 2021.
- Panbela Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$10M, a 74% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)